Action NSTM NOVELSTEM INTERNATIONAL CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues NovelStem International Corp.

Actions

NSTM

US67001V1098

Marché Fermé - OTC Markets
Autres places de cotation
 18:07:06 24/04/2024 		Varia. 5j. Varia. 1 janv.
0,06 USD -.--% Graphique intraday de NovelStem International Corp. -.--% -4,61%
01/04 NovelStem International Corp. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 NovelStem International Corp. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
NovelStem International Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
NovelStem International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
NovelStem International Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
NovelStem International Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
NOVELSTEM INTERNATIONAL CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
NOVELSTEM INTERNATIONAL CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Novelstem International Corp. Appoints Jan Loeb as President
NOVELSTEM INTERNATIONAL CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
NovelStem International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
NOVELSTEM INTERNATIONAL CORP. : Change in Directors or Principal Officers (form 8-K)
NovelStem International Corp. Elects Christine Jenkins as Chief Financial Officer
NovelStem International Corp. Elects Jan Loeb as Principal Executive Officer
NovelStem International Corp. Announces Management Changes
NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing for Approval of its Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; NovelStem Initiates Process to Become Publicly-Reporting with S.E.C. and to Up-List its Shares
NovelStem International Corp and Newstem Ltd. Announce New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and Covid-19 Resistance
NovelStem International Corp.'s Equity Buyback announced on January 16, 2018, has expired.
Hollywood Media Corp. will Change its Ticker to NSTM from HOLL
Hollywood Media Corp. has Changed its Name to NovelStem International Corp
Hollywood Media Corp. Announces Board Changes
NewStem Ltd. announced that it expects to receive $4 million in funding from Hollywood Media Corp.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action NSTM
  4. Actualités NovelStem International Corp.
  5. Autres langues